×
About 2,418 results

ALLMedicine™ Hypopituitarism Center

Research & Reviews  860 results

Perioperative fluctuation and overall evaluation of adenohypophyseal hormone secretion ...
https://doi.org/10.3171/2022.9.FOCUS226
Neurosurgical Focus; Pei Z, Fang Y et. al.

Dec 2nd, 2022 - Perioperative adenohypophyseal hormone assessment can improve therapeutic strategies and be used to evaluate the prognosis of pituitary adenomas. An individual hormone level does not entirely reflect the pituitary gland. Thus, this study aimed to ...

A Case of Sphenoid Mucocele Causing Hypopituitarism.
https://doi.org/10.1177/01455613221142123
Ear, Nose, & Throat Journal; Gozgec E, Ogul H

Nov 26th, 2022 - Mucocele is rarely seen in the sphenoid sinus. It may cause compression of neighboring structures due to significant destruction of the bony structure and its expansile nature. Although headache is the main symptom, it may present with different s...

Adjuvant versus on-progression Gamma Knife radiosurgery for residual nonfunctioning pit...
https://doi.org/10.3171/2022.10.JNS221873
Journal of Neurosurgery; Mantziaris G, Pikis S et. al.

Nov 20th, 2022 - Radiological progression occurs in 50%-60% of residual nonfunctioning pituitary adenomas (NFPAs). Stereotactic radiosurgery (SRS) is a safe and effective management option for residual NFPAs, but there is no consensus on its optimal timing. This s...

Neck Pain and Headache After Pinealectomy: Improvement with Multimodal Chiropractic The...
https://doi.org/10.12659/AJCR.937906
The American Journal of Case Reports; Chu EC, Trager RJ

Nov 20th, 2022 - BACKGROUND Pineal gland tumors are rare central nervous system tumors, and while neck pain and headaches may be common among those who have had these tumors removed, there is little research regarding management of these symptoms. CASE REPORT A 45...

Idiopathic central diabetes insipidus in a large cohort of patients: the hypopituitaris...
https://doi.org/10.1007/s11102-022-01277-1
Pituitary Iraqi HM, Pigarova E et. al.

Oct 20th, 2022 - Central Diabetes Insipidus (CDI) is mainly associated with structural pathologies of the hypothalamic-pituitary area. Etiologies underlying CDI are identified in most patients, however idiopathic CDI is reported in 13-17% of cases after excluding ...

see more →

Guidelines  5 results

Management of immune-related adverse events in endocrine organs induced by immune check...
https://doi.org/10.1507/endocrj.EJ19-0163
Endocrine Journal; Arima H, Iwama S et. al.

Jun 28th, 2019 - Immune checkpoint inhibitors (ICIs) have become a promising treatment for advanced malignancies. However, these drugs can induce immune-related adverse events (irAEs) in several organs, including skin, gastrointestinal tract, liver, muscle, nerve,...

Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practi...
https://doi.org/10.1210/jc.2016-2118
The Journal of Clinical Endocrinology and Metabolism; Fleseriu M, Hashim IA et. al.

Nov 5th, 2016 - To formulate clinical practice guidelines for hormonal replacement in hypopituitarism in adults. The participants include an Endocrine Society-appointed Task Force of six experts, a methodologist, and a medical writer. The American Association for...

Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline for Pr...
https://doi.org/10.1227/NEU.0000000000001387
Neurosurgery Fleseriu M, Bodach ME et. al.

Sep 17th, 2016 - Nonfunctioning pituitary adenomas (NFPAs) are among the most common pituitary lesions and may present with hypopituitarism and/or hyperprolactinemia. To review the existing literature as it pertains to preoperative endocrine assessment in the work...

Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline on Pri...
https://doi.org/10.1227/NEU.0000000000001389
Neurosurgery Lucas JW, Bodach ME et. al.

Sep 17th, 2016 - Nonfunctioning pituitary adenomas (NFPAs) are among the most common pituitary lesions and may present clinically with vision loss and hypopituitarism. To characterize the existing literature as it pertains to the initial management of NFPAs. A sys...

Pituitary incidentaloma: an endocrine society clinical practice guideline.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5393422
The Journal of Clinical Endocrinology and Metabolism; Freda PU, Beckers AM et. al.

Apr 9th, 2011 - The aim was to formulate practice guidelines for endocrine evaluation and treatment of pituitary incidentalomas. Consensus was guided by systematic reviews of evidence and discussions through a series of conference calls and e-mails and one in-per...

see more →

Drugs  2 results see all →

Clinicaltrials.gov  32 results

Quality of Life and Psychosocial Dimension in Children With Hypopituitarism
https://clinicaltrials.gov/ct2/show/NCT05403255

Jun 3rd, 2022 - Objectives: Describe the quality of life and psychosocial repercussions of the disease in children 10-17 years of age with multiple pituitary hormone deficiency (either acquired or congenital), or isolated pituitary hormone deficiency (other than ...

Treatment of Adrenal Insufficiency in Children
https://clinicaltrials.gov/ct2/show/NCT02720952

May 4th, 2022 - This is a Phase 3, open label, single centre study of Infacort® in neonates, infants and children less than 6 years of age with adrenal insufficiency. The study will be conducted in a total of 24 subjects, before their 6th birthday, requiring repl...

Circulating Oxytocin Changes in Response to the Oxytocin System Stimulator MDMA in Patients With Diabetes Insipidus and Healthy Controls
https://clinicaltrials.gov/ct2/show/NCT04648137

Apr 13th, 2022 - Disruption of the hypothalamic-pituitary axis due to congenital abnormalities, tumors or head trauma may cause anterior and/or posterior pituitary deficiency also known as partial or panhypopituitarism. Patients with hypopituitarism, especially th...

Identification and Clinical Relevance of an Oxytocin Deficient State (Melatonin Study)
https://clinicaltrials.gov/ct2/show/NCT05319301

Apr 8th, 2022 - Oxytocin (OT) is a hypothalamic peptide that enters the peripheral circulation via the posterior pituitary gland. OT plays a key role in regulating appetite, psychopathology, prosocial behavior and sexual function. Hypopituitarism is associated wi...

Stimulation Test With Intranasal Glucagon for Corticotroph, Somatotroph and Antidiuretic Axes
https://clinicaltrials.gov/ct2/show/NCT05206149

Jan 25th, 2022 - The diagnosis of secondary hypoadrenalism and GH deficiency (GHD) often requires the performance of a dynamic test. The glucagon stimulation test (GST) is one of the options for evaluating hypothalamic-pituitary function, representing a stimulus f...

see more →

News  57 results

Long COVID Case Study: Persistent Hormone Deficiencies
https://www.medscape.com/viewarticle/979314

Aug 17th, 2022 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. A case study of a 65-year-old man in Japan with long COVID describes how he recovered from certain impaired hormone deficiencies that persisted fo...

Breast Cancer Treatment Advances Lead to Broadened Scope of Personalized Medicine
https://www.onclive.com/view/breast-cancer-treatment-advances-lead-to-broadened-scope-of-personalized-medicine

Mar 21st, 2022 - As a result of many positive trials throughout breast cancer in recent years, the treatment armamentarium has blossomed with CDK4/6 inhibitors, checkpoint inhibitors, and antibody-drug conjugates (ADCs) to name a few, explained Harold J. Burstein,...

Switching Levothyroxine Generics Doesn't Affect TSH Levels, Study Finds
https://www.medpagetoday.com/endocrinology/thyroid/97418

Feb 28th, 2022 - Switching between generic levothyroxine products won't make much of a clinical difference, a new study suggested. In a comparative effectiveness research study of 15,829 patients, those who switched up their generic levothyroxine product didn't se...

Multidisciplinary Care for Malignant Melanoma
https://www.onclive.com/view/multidisciplinary-care-for-malignant-melanoma

Apr 2nd, 2021 - For High-Definition, Click The treatment of patients with metastatic melanoma requires a team approach. The complexities of this disease warrants impute from several specialists to properly deliver care, the panelists agree. Along these lines, h...

I/O Second-Line Treatment
https://www.onclive.com/view/i-o-second-line-treatment

Apr 2nd, 2021 - Peter Galle, MD: What do we have as evidence? The only I/O agent that has been convincing in demonstrating benefit was atezolizumab in combination with bevacizumab in first line. That’s what we have. The monotherapy has not made it into a signific...

see more →

Patient Education  11 results see all →